As another SGLT2 diabetes drug hits the market, the obvious question is: How will it find a way to compete against formidable blockbusters Farxiga and Jardiance?For its recently approved SGLT2 Brenzavvy (bexagliflozin), TheracosBio has a simple and powerful answer—with a price that undercuts the competition by roughly 1,000%.Working through Mark Cuban’s online distributor Cost Plus […]
